LicianPro

Cartesian Therapeutics, Inc. ·

RNAC 8-K 2026-09-29

Cartesian Therapeutics, Inc. (RNAC) 8-K dated 2026-09-29 — accession 0001453687-26-000105.

Cartesian Therapeutics, Inc. (RNAC) is a biotechnology company listed on US.

Cartesian Therapeutics, Inc. filed a 8-K on 2026-09-29. Accession 0001453687-26-000105.

This 8-K covers: Reg FD disclosure (Item 7.01), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported RNAC revenue for 2025-12-31 was $2.8M. Net income was -$130.3M. Revenue was down 92.8% from 2024-12-31 to 2025-12-31. RNAC currently screens at market cap $290.9M.

Not investment advice. The RNAC SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr